Gene · 7075
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emergency communications after earthquake reveal social network backbone of important ties. | PNAS Nexus | 2023 | 38024411 | PubTator, text mining | PubMed |
| Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA. | Clin Med Insights Endocrinol Diabetes | 2023 | 38023736 | PubTator, text mining | PubMed |
| Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning. | Front Oncol | 2023 | 38023262 | PubTator, text mining | PubMed |
| The pathogenesis and potential therapeutic targets in sepsis. | MedComm (2020) | 2023 | 38020710 | PubTator, text mining | PubMed |
| Organotypic heterogeneity in microvascular endothelial cell responses in sepsis-a molecular treasure trove and pharmacological Gordian knot. | Front Med (Lausanne) | 2023 | 38020105 | PubTator, text mining | PubMed |
| Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues. | Int J Mol Sci | 2023 | 38003507 | PubTator, text mining | PubMed |
| Reputations for treatment of outgroup members can prevent the emergence of political segregation in cooperative networks. | Nat Commun | 2023 | 38001105 | PubTator, text mining | PubMed |
| Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape. | Curr Issues Mol Biol | 2023 | 37998753 | PubTator, text mining | PubMed |
| TIE1 and TEK signalling, intraocular pressure, and primary open-angle glaucoma: a Mendelian randomization study. | J Transl Med | 2023 | 37996923 | PubTator, text mining | PubMed |
| A ligand-independent Tie2-activating antibody reduces vascular leakage in models of Clarkson disease. | Sci Adv | 2023 | 37976351 | PubTator, text mining | PubMed |
| Editorial: Emerging talents in comparative immunology: 2022. | Front Immunol | 2023 | 37965318 | PubTator, text mining | PubMed |
| Network Pharmacology Combined with Machine Learning to Reveal the Action Mechanism of Licochalcone Intervention in Liver Cancer. | Int J Mol Sci | 2023 | 37958916 | PubTator, text mining | PubMed |
| Vascular tumors of the liver: A brief review. | Ann Hepatobiliary Pancreat Surg | 2023 | 37953709 | PubTator, text mining | PubMed |
| Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. | Front Immunol | 2023 | 37936692 | PubTator, text mining | PubMed |
| Hemorrhagic retinal arterial macroaneurysm combined with branch retinal artery occlusion treated with intravitreal conbercept injection: A case report. | Medicine (Baltimore) | 2023 | 37904389 | PubTator, text mining | PubMed |
| Vitamin D and COVID-19: An Update on Evidence and Potential Therapeutic Implications. | Cureus | 2023 | 37900412 | PubTator, text mining | PubMed |
| Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study. | J Am Heart Assoc | 2023 | 37889181 | PubTator, text mining | PubMed |
| Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review). | Mol Med Rep | 2023 | 37888611 | PubTator, text mining | PubMed |
| Muscle-invasive angiosarcoma of the urinary bladder: Case report. | Urol Case Rep | 2023 | 37886347 | PubTator, text mining | PubMed |
| Leukocyte cell-derived chemotaxin 2 correlates with pediatric non-alcoholic fatty liver disease. | Clin Transl Sci | 2023 | 37877453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7075/papers?page=7